Tergus Pharma, an end-to-end service provider for topical pharmaceutical research, drug development, testing and manufacturing, today has unveiled a 100,000-square-foot building for its new headquarters and plans to invest to expand into commercial manufacturing. Tergus will provide comprehensive services from development through manufacturing and will become a contract development and manufacturing organization (CDMO).   Tergus has also partnered with Great Point Partners (GPP), a Greenwich, CT...